123 related articles for article (PubMed ID: 11562402)
1. Remodeling of resistance arteries in renal failure: effect of endothelin receptor blockade.
Amann K; Mil Tenberger-Mil Tenyi G; Simonoviciene A; Koch A; Orth S; Ritz E
J Am Soc Nephrol; 2001 Oct; 12(10):2040-2050. PubMed ID: 11562402
[TBL] [Abstract][Full Text] [Related]
2. Endothelin receptor antagonists influence cardiovascular morphology in uremic rats.
Nabokov AV; Amann K; Wessels S; Münter K; Wagner J; Ritz E
Kidney Int; 1999 Feb; 55(2):512-9. PubMed ID: 9987075
[TBL] [Abstract][Full Text] [Related]
3. Endothelin ET(A) receptor blockade prevents the progression of renal failure and hypertension in uraemic rats.
Brochu E; Lacasse S; Moreau C; Lebel M; Kingma I; Grose JH; Larivière R
Nephrol Dial Transplant; 1999 Aug; 14(8):1881-8. PubMed ID: 10462266
[TBL] [Abstract][Full Text] [Related]
4. Blood pressure-independent additive effects of pharmacologic blockade of the renin-angiotensin and endothelin systems on progression in a low-renin model of renal damage.
Amann K; Simonaviciene A; Medwedewa T; Koch A; Orth S; Gross ML; Haas C; Kuhlmann A; Linz W; Schölkens B; Ritz E
J Am Soc Nephrol; 2001 Dec; 12(12):2572-2584. PubMed ID: 11729225
[TBL] [Abstract][Full Text] [Related]
5. Structure and function of small arteries in salt-induced hypertension: effects of chronic endothelin-subtype-A-receptor blockade.
d'Uscio LV; Barton M; Shaw S; Moreau P; Lüscher TF
Hypertension; 1997 Oct; 30(4):905-11. PubMed ID: 9336391
[TBL] [Abstract][Full Text] [Related]
6. Effect of endothelin blockade on early cardiovascular remodeling in the one-clip-two-kidney hypertension of the rat.
Saam T; Ehmke H; Haas C; Ritz E; Amann K
Kidney Blood Press Res; 2003; 26(5-6):325-32. PubMed ID: 14610336
[TBL] [Abstract][Full Text] [Related]
7. Tissue angiotensin II and endothelin-1 modulate differently the response to flow in mesenteric resistance arteries of normotensive and spontaneously hypertensive rats.
Matrougui K; Lévy BI; Henrion D
Br J Pharmacol; 2000 Jun; 130(3):521-6. PubMed ID: 10821779
[TBL] [Abstract][Full Text] [Related]
8. Influence of endothelin receptor antagonists on myocardial protein kinase C isoforms in uraemic cardiomyopathy.
Wolf SC; Amend T; Risler T; Amann K; Brehm BR
Clin Sci (Lond); 2002 Aug; 103 Suppl 48():276S-279S. PubMed ID: 12193103
[TBL] [Abstract][Full Text] [Related]
9. Glomerulosclerosis and progression: effect of subantihypertensive doses of alpha and beta blockers.
Amann K; Koch A; Hofstetter J; Gross ML; Haas C; Orth SR; Ehmke H; Rump LC; Ritz E
Kidney Int; 2001 Oct; 60(4):1309-23. PubMed ID: 11576345
[TBL] [Abstract][Full Text] [Related]
10. Effect of chronic treatment with two different ET(A) selective endothelin receptor antagonists on blood pressure and small artery structure of deoxycorticosterone acetate (DOCA)-salt hypertensive rats.
Li JS; Turgeon A; Schiffrin EL
Am J Hypertens; 1998 May; 11(5):554-62. PubMed ID: 9633791
[TBL] [Abstract][Full Text] [Related]
11. Endothelin-receptor antagonists in uremic cardiomyopathy.
Wolf SC; Gaschler F; Brehm S; Klaussner M; Amann K; Risler T; Brehm BR
J Cardiovasc Pharmacol; 2000 Nov; 36(5 Suppl 1):S348-50. PubMed ID: 11078417
[TBL] [Abstract][Full Text] [Related]
12. Hyperphosphatemia aggravates cardiac fibrosis and microvascular disease in experimental uremia.
Amann K; Törnig J; Kugel B; Gross ML; Tyralla K; El-Shakmak A; Szabo A; Ritz E
Kidney Int; 2003 Apr; 63(4):1296-301. PubMed ID: 12631346
[TBL] [Abstract][Full Text] [Related]
13. Hypertrophy of intramyocardial arteriolar smooth muscle cells in experimental renal failure.
Törnig J; Gross ML; Simonaviciene A; Mall G; Ritz E; Amann K
J Am Soc Nephrol; 1999 Jan; 10(1):77-83. PubMed ID: 9890312
[TBL] [Abstract][Full Text] [Related]
14. Endothelin A receptor blockade prevents capillary/myocyte mismatch in the heart of uremic animals.
Amann K; Münter K; Wessels S; Wagner J; Balajew V; Hergenröder S; Mall G; Ritz E
J Am Soc Nephrol; 2000 Sep; 11(9):1702-1711. PubMed ID: 10966495
[TBL] [Abstract][Full Text] [Related]
15. Enhanced endothelin-1-induced contractions in mesenteric arteries from rats with congestive heart failure: role of ET(B) receptors.
Bergdahl A; Valdemarsson S; Adner M; Sun XY; Hedner T; Edvinsson L
Eur J Heart Fail; 2001 Jun; 3(3):293-9. PubMed ID: 11377999
[TBL] [Abstract][Full Text] [Related]
16. ET(A) receptor antagonist prevents blood pressure elevation and vascular remodeling in aldosterone-infused rats.
Park JB; Schiffrin EL
Hypertension; 2001 Jun; 37(6):1444-9. PubMed ID: 11408393
[TBL] [Abstract][Full Text] [Related]
17. Transient involvement of endothelin in hypertrophic remodeling of small arteries.
Dao HH; Martens FM; Larivière R; Yamaguchi N; Cernacek P; de Champlain J; Moreau P
J Hypertens; 2001 Oct; 19(10):1801-12. PubMed ID: 11593100
[TBL] [Abstract][Full Text] [Related]
18. Combination treatment with an ET(A)-receptor blocker and an ACE inhibitor is not superior to the respective monotherapies in attenuating chronic transplant vasculopathy in different aorta allotransplantation rat models.
Orth SR; Odoni G; Karkoszka H; Ogata H; Viedt C; Amann K; Ferrari P; Ritz E
Nephrol Dial Transplant; 2003 Jan; 18(1):62-9. PubMed ID: 12480961
[TBL] [Abstract][Full Text] [Related]
19. Effects of low dose sympathetic inhibition on glomerulosclerosis and albuminuria in subtotally nephrectomized rats.
Amann K; Rump LC; Simonaviciene A; Oberhauser V; Wessels S; Orth SR; Gross ML; Koch A; Bielenberg GW; VAN Kats JP; Ehmke H; Mall G; Ritz E
J Am Soc Nephrol; 2000 Aug; 11(8):1469-1478. PubMed ID: 10906160
[TBL] [Abstract][Full Text] [Related]
20. Mechanical properties of mesenteric resistance arteries from Dahl salt-resistant and salt-sensitive rats: role of endothelin-1.
Intengan HD; Schiffrin EL
J Hypertens; 1998 Dec; 16(12 Pt 2):1907-12. PubMed ID: 9886876
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
